In silico evidences of Mpro inhibition by a series of organochalcogen-AZT derivatives and their safety in Caenorhabditis elegans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In silico evidences of Mpro inhibition by a series of organochalcogen-AZT derivatives and their safety in Caenorhabditis elegans

Published:2023-12 Issue: Volume:80 Page:127297
ISSN:0946-672X
Container-title:Journal of Trace Elements in Medicine and Biology
language:en
Short-container-title:Journal of Trace Elements in Medicine and Biology

Author:

Viçozzi Gabriel Pedroso,de Oliveira Pereira Flávia Suelen,da Silva Rafael Santos,Leal Julliano Guerin,Sarturi Joelma Menegazzi.,Nogara Pablo Andrei,Rodrigues Oscar Endrigo Dorneles,Teixeira da Rocha João Batista,Ávila Daiana Silva

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Universidade Federal de Santa Maria

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Molecular Medicine,Biochemistry

Reference57 articles.

1. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors;Jin;Nature,2020

2. Nucleotide analogues as inhibitors of SARS-CoV-2 polymerase, a key drug target for COVID-19;Chien;J. Proteome Res,2020

3. Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection;Copertino;J. Biomol. Struct. Dyn.,2021

4. A review on the new indication of nucleoside reverse transcriptase inhibitors (NRTIs) in the treatment of coronavirus disease 2019;Karbasforooshan;Infect. Disord. - Drug Targets,2022

5. Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2;Yadav;J. Biomol. Struct. Dyn.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP